Non-Hodgkin lymphoma (NHL) comprises a diverse group of cancers that develop from lymphocytes, a type of white blood cell involved in the immune system.

It is one of the most common cancers in the United States, accounting for about 4% of all cancers.

Because NHL includes multiple biological and molecular subtypes, researchers rely on well-characterized patient-derived biospecimens to investigate disease biology, biomarkers, progression, treatment response, and therapeutic resistance.

At Bay Biosciences, we understand this need and provide high-quality non-Hodgkin lymphoma plasma samples, along with other human biospecimens, including serum, peripheral blood mononuclear cells (PBMCs), whole blood, etc.

Non-Hodgkin Lymphoma Plasma Samples

Understanding Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma develops when abnormal lymphocytes grow and survive in an uncontrolled manner.

These malignant cells may arise from B cells, T cells, or other lymphocyte populations and can involve lymph nodes, bone marrow, blood, the spleen, or extranodal tissues.

Common B-cell NHL subtypes include diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma, while T-cell lymphomas represent another major category.

This biological diversity makes appropriately characterized lymphoma biospecimens for research valuable for studies investigating disease mechanisms and biomarkers.

Signs and Symptoms of Non-Hodgkin Lymphoma

The signs and symptoms of NHL can vary depending on the lymphoma subtype and the tissues involved.

Common manifestations include:

Some patients may have few noticeable symptoms during the early stages of disease.

Clinical presentation can therefore vary substantially between individual lymphoma subtypes.

Causes of Non-Hodgkin Lymphoma

The exact cause of many cases of non-Hodgkin lymphoma is not fully understood. However, modern research points to several factors that are linked to its development.

The role of genetic and molecular alterations that affect the normal growth, survival, and regulation of lymphocytes is one such important factor.

Similarly, viral infections, immune system dysfunction, chronic immune stimulation, and other biological processes have also been associated with specific forms of lymphoma.

Some lymphoma-associated alterations occur during a person’s lifetime, while certain inherited or immune-related factors may influence susceptibility.

Researchers continue to investigate the genetic, epigenetic, immune, and environmental mechanisms involved in lymphoma development.

Risk Factors for Non-Hodgkin Lymphoma

Several factors may increase the likelihood of developing NHL.

Firstly, older age is associated with an increased risk of many NHL subtypes.

Secondly, immune system dysfunction can contribute to lymphoma risk. Individuals with certain immune deficiencies or conditions that affect immune regulation may be more susceptible.

Thirdly, some infections are associated with particular lymphoma types.

Finally, family history, autoimmune conditions, and other biological or environmental factors may contribute to lymphoma risk in specific populations.

However, it is important to highlight that many individuals who develop NHL do not have a clearly identifiable risk factor.

Diagnosis of Non-Hodgkin Lymphoma

Diagnosis generally begins with a clinical evaluation followed by laboratory testing and imaging studies when lymphoma is suspected.

Imaging techniques such as computed tomography (CT), positron emission tomography (PET), or other scans may be used to evaluate enlarged lymph nodes and identify areas of disease involvement.

A biopsy is commonly required to establish the diagnosis and determine the specific lymphoma subtype.

Moreover, Blood and bone marrow studies can also be used as they provide useful additional information, particularly when lymphoma involves circulating cells or the bone marrow.

Treatment of Non-Hodgkin Lymphoma

Treatment depends on the lymphoma subtype, stage, molecular characteristics, disease location, symptoms, and overall health of the patient.

Firstly, Chemotherapy remains an important treatment approach for several NHL subtypes.

Secondly, depending on the disease, chemotherapy may be combined with antibody-based or other targeted therapies.

Thirdly, Immunotherapy has also become an important area of lymphoma treatment research.

Moreover, Certain antibody therapies and other immune-based approaches are used for selected lymphoma subtypes.

Furthermore, Radiation therapy may be used in specific clinical settings, while stem cell transplantation can be considered for selected patients with particular forms of lymphoma.

Applications of Non-Hodgkin Lymphoma Plasma Samples for Research

Well-characterized non-Hodgkin lymphoma plasma samples can support a range of studies investigating circulating biomarkers, molecular characteristics, disease progression, and treatment response.

Lymphoma PBMC Samples for Research

Lymphoma PBMC samples for research can support investigations into circulating immune cells and host immune responses.

PBMCs contain lymphocytes and monocytes that can be evaluated using cellular, immunological, molecular, and functional research methods.

Human Lymphoma Tissue Samples for Research

Human lymphoma tissue samples for research provide direct access to tumor material for histopathological, molecular, and genomic investigations.

Researchers may study tissue alongside plasma to compare tumor-derived alterations with circulating biomarkers.

Human Lymphoma Tissue and Blood Samples

Human lymphoma tissue and blood samples provide complementary information about the tumor and systemic biological environment.

Combining tissue, plasma, serum, PBMCs, and whole blood can help researchers investigate relationships between tumor characteristics, circulating biomarkers, and immune responses.

Lymphoma Tumor Tissue for Research

Lymphoma tumor tissue for research supports studies of tumor morphology, molecular alterations, biomarker expression, and mechanisms of disease progression.

When tumor tissue is paired with non-Hodgkin lymphoma plasma samples, researchers can investigate both tissue-associated and circulating biological features.

Frequently Asked Questions

What are non-Hodgkin lymphoma plasma samples?

Non-Hodgkin lymphoma plasma samples are plasma specimens obtained from individuals diagnosed with non-Hodgkin lymphoma. They can be used to investigate circulating biomarkers, cell-free DNA, immune-related factors, and other biological characteristics associated with NHL.

What are lymphoma biospecimens for research used for?

Lymphoma biospecimens for research can support studies of tumor biology, biomarkers, molecular alterations, immune responses, disease progression, treatment response, and therapeutic development.

What can researchers study using NHL serum and plasma samples?

NHL serum samples for research and plasma specimens can be investigated for circulating proteins, immune markers, nucleic acids, and other analytes. Plasma-based liquid biopsy research has also examined cfDNA and ctDNA for molecular characterization and measurable residual disease applications.

Supporting Your Research with Bay Biosciences

At Bay Biosciences, we have a comprehensive range of high-quality human biospecimens.

Some of these include:

If you have any questions, concerns, or special requests, please don’t hesitate to reach out to us!